HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase.
| Institute |
|---|
| University of Cambridge |
| Cat. #: | 151213 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction |
| Application: | ELISA ; WB ; ELISA ; IHC ; WB |
| Target: | Hepatocyte Growth Factor/Scatter Factor (HGF/SF) |
| Reactivity: | Human |
| Clone: | EGH2 4C12.1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG2b |
| Immunogen: | Recombinant Human HGF/SF |
| Myeloma used: | NS0 |
| Target background: | HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation Bai et al. 2017. Exp Ther Med. 13(6):2876-2882. PMID: 28587353. In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor Arends et al. 2008. Vet J. 178(1):70-7. PMID: 18314358. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.